A peptide Certificate of Analysis should connect the exact batch to test methods, identity checks, purity results, and accountable lab information. Read it as a quality document, not as a medical promise.
A peptide Certificate of Analysis should connect the exact batch to test methods, identity checks, purity results, and accountable lab information. Read it as a quality document, not as a medical promise.
Educational content. Not medical advice and not a claim that Peptyds products diagnose, treat, cure, or prevent disease.
The first check is whether the CoA belongs to the exact batch being sold. A useful certificate should make the sample, batch identifier, test date, method, and result traceable.[3][1]
ISO/IEC 17025 helps testing laboratories demonstrate competence and the ability to generate valid results; it does not by itself say that a peptide has a clinical effect.[1]
HPLC is commonly used to separate components in a peptide sample and estimate purity by peak area, while mass spectrometry is used to support molecular identity.[4]
Regulatory analytical guidance treats validation as a question of fitness for purpose: accuracy, specificity, precision, range, and related characteristics matter when a method supports a quality decision.[2]
For buyers, a clean-looking purity percentage is useful only when the certificate also shows what method produced it and which batch it belongs to.
Peptyds should keep quality proof close to the product page: batch code first, method context second, and plain-language interpretation third.
No. HPLC estimates how much of the detected chromatographic signal belongs to the main peak. Identity is usually supported by mass spectrometry or another suitable identity method.[4]
No. ISO/IEC 17025 is a laboratory competence standard. It does not approve a product or support a medical claim.[1]